Maag Lever Darm Stichting
11
3
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Gut Health Enhancement by Eating Favourable Food
Role: collaborator
Promoting Early Diagnosis of Chronic Mesenteric Ischemia
Role: collaborator
The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study
Role: collaborator
AADC/TDC in Advanced Parkinson's Disease
Role: collaborator
Standardising Care for Hepatitis Delta in the Netherlands
Role: collaborator
Performance of a Single-use Gastroscope (aScope Gastro) for Esophagogastroduodenoscopy
Role: collaborator
The Clock Thickens: Morning or Evening Training for the Treatment of NAFLD?
Role: collaborator
PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer
Role: collaborator
The Detrimental Course of Acute Intestinal Ischemia
Role: collaborator
Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study
Role: collaborator
Improving Constipation by Stimulating Fiber Intake Using Personalized Dietary Advice
Role: collaborator
All 11 trials loaded